OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease
Ting He, Xiaoyan Lin, Anping Su, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Ting He, Xiaoyan Lin, Anping Su, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Showing 12 citing articles:
Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation
Olga Golubnitschaja, Andrea Kapinová, Nafiseh Sargheini, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 163-205
Open Access | Times Cited: 10
Olga Golubnitschaja, Andrea Kapinová, Nafiseh Sargheini, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 163-205
Open Access | Times Cited: 10
Effect of Diacetylcurcumin Manganese Complex on Rotenone-Induced Oxidative Stress, Mitochondria Dysfunction, and Inflammation in the SH-SY5Y Parkinson’s Disease Cell Model
Ekanong Pirunkaset, Chantana Boonyarat, Juthamart Maneenet, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 957-957
Open Access | Times Cited: 5
Ekanong Pirunkaset, Chantana Boonyarat, Juthamart Maneenet, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 957-957
Open Access | Times Cited: 5
Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review
Yingfan Chen, Zhenhui Wu, Shaodan Li, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1053-1081
Open Access | Times Cited: 4
Yingfan Chen, Zhenhui Wu, Shaodan Li, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1053-1081
Open Access | Times Cited: 4
The delayed effect of rotenone on the relative content of brain isatin-binding proteins of rats with experimental parkinsonism
О.А. Бунеева, И. Г. Капица, L.Sh. Kazieva, et al.
Biomeditsinskaya Khimiya (2024) Vol. 70, Iss. 1, pp. 25-32
Closed Access | Times Cited: 2
О.А. Бунеева, И. Г. Капица, L.Sh. Kazieva, et al.
Biomeditsinskaya Khimiya (2024) Vol. 70, Iss. 1, pp. 25-32
Closed Access | Times Cited: 2
Amendment of Altered Immune Response by Curcumin in Drosophila Model of Huntington’s Disease
Jyoti Dhankhar, Anju Shrivastava, Namita Agrawal
Journal of Huntington s Disease (2023) Vol. 12, Iss. 4, pp. 335-354
Open Access | Times Cited: 5
Jyoti Dhankhar, Anju Shrivastava, Namita Agrawal
Journal of Huntington s Disease (2023) Vol. 12, Iss. 4, pp. 335-354
Open Access | Times Cited: 5
Natural products for the treatment of depression: Insights into signal pathways influencing the hypothalamic–pituitary–adrenal axis
Jiawen Liu, Tianwei Meng, Chaojie Wang, et al.
Medicine (2023) Vol. 102, Iss. 44, pp. e35862-e35862
Open Access | Times Cited: 5
Jiawen Liu, Tianwei Meng, Chaojie Wang, et al.
Medicine (2023) Vol. 102, Iss. 44, pp. e35862-e35862
Open Access | Times Cited: 5
Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Stroke by Attenuating Oxidative Stress and Neuroinflammation
Qinglu Yang, Ruitong Li, Yigen Hong, et al.
(2024)
Closed Access
Qinglu Yang, Ruitong Li, Yigen Hong, et al.
(2024)
Closed Access
Integrated Network Pharmacology and Transcriptomics to Explore the Mechanism of Compound Dihuang Granule (CDG) Protects Dopaminergic Neurons by Regulating the Nrf2/HMOX1 Pathway in the 6-OHDA/MPP+ -Induced Model of Parkinson's Disease
Xue Sun, Shuai Yang, Zhu-qing He, et al.
Research Square (Research Square) (2024)
Closed Access
Xue Sun, Shuai Yang, Zhu-qing He, et al.
Research Square (Research Square) (2024)
Closed Access
Mitochondrial Dysfunction as a Potential Mechanism Mediating Cardiac Comorbidities in Parkinson’s Disease
Alberto Torres, Jieun Lee, Andrea Caporali, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10973-10973
Open Access
Alberto Torres, Jieun Lee, Andrea Caporali, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10973-10973
Open Access
Mitochondria-targeting therapeutic strategies for chronic kidney disease
Annie Sun, Carol A. Pollock, Chunling Huang
Biochemical Pharmacology (2024), pp. 116669-116669
Open Access
Annie Sun, Carol A. Pollock, Chunling Huang
Biochemical Pharmacology (2024), pp. 116669-116669
Open Access
Integrated network pharmacology and transcriptomics to explore the mechanism of compound Dihuang granule (CDG) protects dopaminergic neurons by regulating the Nrf2/HMOX1 pathway in the 6-OHDA/MPP+-induced model of Parkinson’s disease
Xue Sun, Shuai Yang, Zhu-qing He, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access
Xue Sun, Shuai Yang, Zhu-qing He, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access
Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by Attenuating Oxidative Stress and Neuroinflammation
Qinglu Yang, Ruitong Li, Yigen Hong, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 11633-11649
Open Access
Qinglu Yang, Ruitong Li, Yigen Hong, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 11633-11649
Open Access
